Keywords: plavix, deal, fails, get, antitrust, ok, pharmaceutical
Plavix deal fails to get US antitrust OK
Article | 07 August 2006
US pharmaceutical major Bristol-Myers Squibb and leading French drugmaker Sanofi-Aventis say that their agreement, as amended, with Canada-headquartered generics group ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
